HomeCompareKUBTY vs JNJ

KUBTY vs JNJ: Dividend Comparison 2026

KUBTY yields 1.95% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KUBTY wins by $45.4K in total portfolio value
10 years
KUBTY
KUBTY
● Live price
1.95%
Share price
$83.57
Annual div
$1.63
5Y div CAGR
45.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75.7K
Annual income
$22,221.64
Full KUBTY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — KUBTY vs JNJ

📍 KUBTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKUBTYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KUBTY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KUBTY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KUBTY
Annual income on $10K today (after 15% tax)
$165.80/yr
After 10yr DRIP, annual income (after tax)
$18,888.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, KUBTY beats the other by $14,902.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KUBTY + JNJ for your $10,000?

KUBTY: 50%JNJ: 50%
100% JNJ50/50100% KUBTY
Portfolio after 10yr
$53.0K
Annual income
$13,455.52/yr
Blended yield
25.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KUBTY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
1.8
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KUBTY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKUBTYJNJ
Forward yield1.95%2.13%
Annual dividend / share$1.63$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR45.3%28%
Portfolio after 10y$75.7K$30.3K
Annual income after 10y$22,221.64$4,689.40
Total dividends collected$50.6K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: KUBTY vs JNJ ($10,000, DRIP)

YearKUBTY PortfolioKUBTY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,983$283.42$10,592$272.30+$391.00KUBTY
2$12,175$422.72$11,289$357.73+$886.00KUBTY
3$13,664$636.30$12,123$472.89+$1.5KKUBTY
4$15,590$969.70$13,141$629.86+$2.4KKUBTY
5$18,183$1,502.43$14,408$846.81+$3.8KKUBTY
6$21,836$2,379.65$16,021$1,151.60+$5.8KKUBTY
7$27,245$3,880.52$18,122$1,588.22+$9.1KKUBTY
8$35,727$6,574.86$20,930$2,228.20+$14.8KKUBTY
9$49,936$11,707.89$24,792$3,191.91+$25.1KKUBTY
10$75,653$22,221.64$30,274$4,689.40+$45.4KKUBTY

KUBTY vs JNJ: Complete Analysis 2026

KUBTYStock

Kubota Corporation manufactures and markets machinery and related solutions in the food, water, and environment markets in Japan, North America, Europe, Asia, and internationally. It operates in three segments: Farm & Industrial Machinery, Water & Environment, and Other. The Farm & Industrial Machinery segment offers tractors, power tillers, combine harvesters, rice transplanters, turf equipment, utility vehicles, other agricultural machinery, implements, attachments, post-harvest machinery, vegetable production equipment, and other agricultural equipment; cooperative drying, rice seedling, and gardening facilities; rice mill plants; scales, weighing and measuring control systems, and air purifiers; engines for farming, construction, industrial machinery, and generators; and mini excavators, wheel and skid steer loaders, compact track and, and other construction machinery related products. The Water & Environment segment provides ductile iron and plastic pipes, valves, and single stack drain fittings, as well as design and construction services; reformer and cracking tubes, hearth and steel mill rolls, TXAX friction materials, and spiral welded steel pipes; air-conditioning equipment; wastewater treatment equipment and plants, pumps and plants, membrane solutions, flue gas desulfurization apparatus, membrane methane fermentation plants, and bathtubs; and water purification, night-soil treatment, waste incinerating and melting, and waste shredding and sorting plants. The Other segment offers logistics; and roofing and siding materials. The company also engages in non-life insurance underwriting, finance leasing and factoring services, building maintenance, security guarding, transportation, storage, distribution, and cargo handling businesses; and export and import of repair parts related to farm equipment, engines, and construction machinery. It serves customers through a network of dealers. The company was founded in 1890 and is headquartered in Osaka, Japan.

Full KUBTY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this KUBTY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KUBTY vs SCHDKUBTY vs JEPIKUBTY vs OKUBTY vs KOKUBTY vs MAINKUBTY vs ABBVKUBTY vs MRKKUBTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.